The Middle East & Africa glucose monitoring devices market is expected to grow from US$ 935.02 million in 2022 to US$ 1,736.39 million by 2030. It is estimated to grow at a CAGR of 8.0% from 2022 to 2030.
Based on type, the Middle East & Africa glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the Middle East & Africa glucose monitoring devices market in 2022.
Based on application, the Middle East & Africa glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the Middle East & Africa glucose monitoring devices market in 2022.
Based on testing site, the Middle East & Africa glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the Middle East & Africa glucose monitoring devices market in 2022.
Based on end user, the Middle East & Africa glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the Middle East & Africa glucose monitoring devices market in 2022.
Based on country, the Middle East & Africa glucose monitoring devices market is segmented int o the Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa glucose monitoring devices market in 2022.
B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the Middle East & Africa glucose monitoring devices market.
Rising Incidence of Diabetes Fuel Middle East & Africa Glucose Monitoring Devices Market
Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes - diabetes type-I (also known as diabetes insipidus) and diabetes type-II (also termed diabetes mellitus). The incidence and prevalence of diabetes are steadily increasing across the world. Type 2 diabetes is the most prevalent form of diabetes and has increased alongside cultural and societal changes. In high-income countries, up to 91% of adults with the disease have type 2 diabetes. According to International Diabetes Federation (IDF), approximately 537 million people were living with diabetes in 2021 and is expected to reach 738 million by 2045 globally.Middle East & Africa Glucose Monitoring Devices Market Overview
The Middle East & Africa Middle East & Africa Glucose Monitoring Devices Market has been segmented into the Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa. The market growth in Saudi Arabia is high attributed to the big pool of diabetic population in the country. South Africa holds second largest share in terms of continuous glucose monitoring owing to high prevalence of diabetes in the country. The aforementioned factors are responsible for influential growth of Middle East & Africa Glucose Monitoring Devices Market in the Middle East & Africa region.Middle East & Africa Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Glucose Monitoring Devices Market Segmentation
The Middle East & Africa glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.Based on type, the Middle East & Africa glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the Middle East & Africa glucose monitoring devices market in 2022.
Based on application, the Middle East & Africa glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the Middle East & Africa glucose monitoring devices market in 2022.
Based on testing site, the Middle East & Africa glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the Middle East & Africa glucose monitoring devices market in 2022.
Based on end user, the Middle East & Africa glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the Middle East & Africa glucose monitoring devices market in 2022.
Based on country, the Middle East & Africa glucose monitoring devices market is segmented int o the Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa glucose monitoring devices market in 2022.
B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the Middle East & Africa glucose monitoring devices market.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Middle East & Africa Glucose Monitoring Devices Market - Key Industry Dynamics
5. Middle East & Africa Glucose Monitoring Devices Market - Market Analysis
6. Middle East & Africa Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Type
7. Middle East & Africa Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Application
8. Middle East & Africa Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Testing Site
9. Middle East & Africa Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by End User
10. Middle East & Africa Glucose Monitoring Devices Market - Revenue and Forecast to 2030 -Country Analysis
11. Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Executive Summary
At 8.0% CAGR, the Middle East & Africa Glucose Monitoring Devices Market is Speculated to be Worth US$ 1,736.39 million by 2030.According to this research, the Middle East & Africa glucose monitoring devices market was valued at US$ 935.02 million in 2022 and is expected to reach US$ 1,736.39 million by 2030, registering a CAGR of 8.0% from 2022 to 2030. Rapid technological advancements in glucose monitoring devices is a critical factor attributed to the Middle East & Africa glucose monitoring devices market expansion.
Products with advanced technologies offer more effective benefits in diabetes treatment. As the prevalence of diabetes increases worldwide, the demand for more products with advancements also accelerates. Thus, researchers have been carrying out research activities resulting in product innovations over the years. There are many methods to deliver insulin into the body, such as needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin to deliver a slow, continuous insulin level. The individual can control the program depending on the requirements. Optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in glucose monitoring devices have resulted in smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose meter and glucose monitoring devices has also been improved. The increasing advancements in blood glucose monitoring technology have improved accuracy, smaller required blood volumes, and the ability to transfer data between the blood glucose meter and glucose monitoring devices. In June 2022, Abbott announced a new bio wearable that continuously monitors glucose and ketone levels in one sensor. Thus, the technological advancements coupled with the increasing influx of new products are expected to propel the market growth over the forecast years.
On the contrary, high cost of glucose monitoring devices hampers the Middle East & Africa glucose monitoring devices market.
Based on type, the Middle East & Africa glucose monitoring devices market is bifurcated into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices held 58.6% share of Middle East & Africa glucose monitoring devices market in 2022, amassing US$ 547.83 million. It is projected to garner US$ 991.62 million by 2030 to expand at 7.7% CAGR during 2022-2030.
Based on application, the Middle East & Africa glucose monitoring devices market is bifurcated into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held 62.2% share of Middle East & Africa glucose monitoring devices market in 2022, amassing US$ 581.50 million. It is projected to garner US$ 1,063.37 million by 2030 to expand at 7.8% CAGR during 2022-2030.
Based on testing site, the Middle East & Africa glucose monitoring devices market is bifurcated into fingertip testing and alternate site testing. The fingertip testing segment held 65.6% share of Middle East & Africa glucose monitoring devices market in 2022, amassing US$ 613.51 million. It is projected to garner US$ 1,165.78 million by 2030 to expand at 8.4% CAGR during 2022-2030.
Based on end user, the Middle East & Africa glucose monitoring devices market is bifurcated into healthcare setting and self/homecare. The self/homecare segment held 59.7% share of Middle East & Africa glucose monitoring devices market in 2022, amassing US$ 557.95 million. It is projected to garner US$ 999.48 million by 2030 to expand at 7.6% CAGR during 2022-2030.
Based on country, the Middle East & Africa glucose monitoring devices market has been categorized into the Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 35.6% share of Middle East & Africa glucose monitoring devices market in 2022. It was assessed at US$ 333.33 million in 2022 and is likely to hit US$ 635.56 million by 2030, exhibiting a CAGR of 8.4% during 2022-2030.
Key players operating the Middle East & Africa glucose monitoring devices market are B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp, among others.
In Mar-2022, Medtronic plc announced that reimbursement for continuous glucose monitoring (CGM) had been recently expanded or initiated in several countries throughout North and South America. CGM systems provide critical information on glucose levels to help simplify the management of diabetes. In June-2023, Senseonics Holdings, Inc. announced that UnitedHealthcare, the largest health insurance company in the United States, began providing coverage for the Eversense E3 CGM System effective July 1, 2023, for people with type 1 and insulin-requiring type 2 diabetes.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- B. Braun SE
- F. Hoffmann-La Roche Ltd
- Medtronic Plc
- Abbott Laboratories
- Ypsomed Holding AG
- Nipro Corp
- GE HealthCare Technologies Inc
- Terumo Corp
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 97 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 935.02 Million |
| Forecasted Market Value by 2030 | 1736.39 Million |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Africa, Middle East |
